Skip to content
Stem cell therapy for American patients at Boston Health Longevity, Chiang Mai
American Patient Guide

Stem Cell Therapy Thailand for US Patients

Why American patients are travelling to Chiang Mai for stem cell therapy unavailable in the US

Medical direction by Dr Michael Ackland, MBBS (Hons), FRACGP, CEO of Boston Health Longevity

Regulatory Access

Treatments not FDA-approved in the US

Cost Advantage

Significant savings vs US experimental clinics

Language

English-speaking clinical team

Visa

Visa-free entry up to 60 days

Understanding Your Options

Why American Patients Seek Stem Cell Therapy Abroad

The FDA has approved only one MSC-based product for a specific blood condition. For the vast majority of conditions, including osteoarthritis, multiple sclerosis, autoimmune disorders, and neurological disease, umbilical cord-derived MSC therapy is classified as an investigational drug in the United States. This means it cannot be commercially offered by US clinics outside of approved clinical trials.

US patients who have explored domestic options often encounter a significant gap: clinics offering unregulated or poorly standardised products, prohibitively high pricing for participation in private studies, or an outright absence of options for their specific condition. The regulatory environment, while well-intentioned, leaves a large population of patients without access to treatments that are responsibly offered in other jurisdictions.

Thailand has developed one of the most established medical tourism ecosystems in the world. Its regulatory framework supports the responsible clinical provision of advanced regenerative therapies that remain restricted in the US, giving American patients access to high-quality, physician-led protocols in a modern clinical environment.

Content medically reviewed by Dr Michael Ackland, MBBS (Hons), FRACGP, Lead Medical Strategist at Boston Health Longevity.

Why Thailand

Why Thailand Is the Preferred Destination for American Patients

Boston Health Longevity was founded by Dr Michael Ackland, MBBS (Hons), FRACGP, CEO, who maintains an active practice between Boston, USA and Chiang Mai, spending six months per year on-site in Thailand. His American clinical connection provides a unique bridge of understanding for US patients navigating the regulatory gap between domestic limitations and international access.
Unlike many offshore stem cell clinics marketed to American patients, Boston Health Longevity uses only GMP-certified, umbilical cord-derived MSCs with full certificates of analysis. Every treatment protocol is designed by a credentialled physician team. We do not offer unvalidated or poorly characterised cell products.
The cost of regenerative treatment in Thailand is significantly lower than equivalent private experimental programmes in the United States. The same clinical standards, physician oversight, and cell quality are available at a fraction of the cost, including travel and accommodation.
Thailand provides a regulatory framework that supports the responsible clinical use of allogeneic MSC therapy. Boston Health Longevity operates transparently within this framework, with clear protocols, informed consent processes, and structured follow-up.
Chiang Mai's international airport, modern healthcare infrastructure, English-speaking clinical teams, and world-class accommodation make it one of the most accessible destinations for long-haul medical travel from the United States.
Travel & Logistics

Getting to Chiang Mai from New York

Flight Details

There are no direct flights from the United States to Chiang Mai. Common routing options include: Los Angeles or San Francisco via Tokyo Narita (~18-20 hours), New York via Hong Kong (~20-22 hours), or any US gateway via Bangkok Suvarnabhumi with a domestic connection to Chiang Mai (~16-20 hours total). Airlines including Thai Airways, Cathay Pacific, JAL, ANA, and Korean Air service these routes. Chiang Mai International Airport (CNX) is a 20-minute taxi from the clinic.

Visa Information

US passport holders can enter Thailand visa-free for up to 60 days. No prior visa application or embassy visit is required. This is sufficient for treatment, recovery, and any additional time you wish to spend in Chiang Mai before returning to the US.

Language Support

English is the primary clinical language at Boston Health Longevity. All consultations, treatment reports, informed consent documentation, and follow-up communications are conducted in English. There are no language barriers for American patients.

Accommodation

Chiang Mai offers a wide range of accommodation suited to American visitors, from internationally branded five-star hotels to comfortable boutique residences. Our patient coordination team provides specific recommendations based on your preferences and whether family members are accompanying you. Extended-stay options with kitchen facilities are available for patients staying two weeks or longer.

Flight Time

~16-20 hours via Tokyo, Seoul, or Bangkok

Timezone

Thailand is 11-14 hours ahead of US time zones

Currency

USD

Your Journey

The Patient Pathway from New York

1

Apply Online

Complete our online application form. An American-English-speaking patient coordinator will respond within 24 hours with an initial assessment of your suitability for stem cell therapy.

2

Remote Medical Review

Your medical records, imaging (MRI, CT scans, blood panels), and health history are reviewed by our clinical team in Chiang Mai. A detailed video consultation is conducted to discuss your condition, available protocols, and realistic expected outcomes.

3

Travel Planning

Once clinical suitability is confirmed, our team assists with travel planning, accommodation, and your full treatment schedule. We provide guidance on flight routing, arrival logistics, and pre-travel health preparation.

4

On-Site Treatment

Arrive in Chiang Mai for your clinical assessment and personalised stem cell therapy protocol. Treatment duration ranges from one to several days depending on your condition. Private airport transfers are arranged.

5

Return to the US and Follow-Up

Return home with a comprehensive aftercare plan and discharge summary. Structured remote follow-up consultations are conducted at 1, 3, 6, and 12 months via secure video call. We can coordinate with your US physician or specialist if required.

Ready to explore your options?

Our American patient coordinator responds within 24 hours. No obligation, completely confidential.

Apply for Consultation
Available Treatments

Popular Treatments for American Patients

Each treatment is individually tailored to your health profile. There are no standard packages. Your physician designs a protocol specific to your needs and clinical assessment.

Knee and hip osteoarthritis
Multiple sclerosis
Parkinson's disease
Autoimmune conditions including lupus and rheumatoid arthritis
Anti-ageing and longevity protocols
Neurological conditions and nerve damage

Conditions Commonly Treated

Treatment Access & Pricing

Availability in New York vs Chiang Mai

Understanding what treatments are available in your home country and what Boston Health Longevity offers in Chiang Mai.

Treatment New York Availability Chiang Mai (Boston Health Longevity)
Single Joint Stem Cell Therapy Not commercially available (FDA investigational) $5,000-$12,000 USD
Neurological Stem Cell Protocol Clinical trial access only, extremely limited $18,000-$35,000 USD
Autoimmune Stem Cell Programme Not commercially available in the US $12,000-$28,000 USD
Anti-Ageing and Longevity Protocol Limited and largely unregulated in the US $8,000-$20,000 USD

Thailand costs are indicative ranges only. Final pricing depends on your specific condition, protocol, and duration of treatment. All pricing is provided transparently during your remote consultation.

UC-MSC stem cell therapy is not commercially available in the United States for most conditions. American patients who pursue these treatments domestically typically do so through private experimental programmes at significant cost. Boston Health Longevity in Chiang Mai offers the same clinical standards, GMP-certified cell products, and physician-led protocols at a fraction of the cost of US alternatives, with full transparency on pricing provided during your remote consultation.

Sample Schedule

Sample American Patient Itinerary

A typical 7-day treatment programme for patients travelling from New York. Your itinerary is personalised based on your treatment protocol.

D1

Arrival in Chiang Mai

Arrive at Chiang Mai International Airport after your long-haul flight. Private transfer to your hotel. Rest and recover from jet lag. Welcome call from your US-English-speaking patient coordinator.

D2

Clinical Assessment

Comprehensive health assessment with your physician. Blood panel, biomarker analysis, diagnostic imaging review, and personalised treatment planning. All documentation in English.

D3

Treatment Day

Your personalised stem cell therapy protocol is administered under full clinical supervision at Boston Health Longevity. Monitoring continues throughout the day.

D4

Rest and Recovery

A dedicated recovery day. Light activity encouraged. Explore Chiang Mai's Old City, temples, and renowned cuisine, or simply rest at your hotel.

D5

Follow-Up and Monitoring

Post-treatment clinical review with your physician. Additional monitoring or supplementary treatment if clinically indicated. Blood work if required.

D6

Discharge and US Aftercare Plan

Comprehensive discharge review. You receive your personalised aftercare plan, a detailed treatment report suitable for sharing with your US physician, and your remote follow-up schedule.

D7

Departure

Private airport transfer for your return journey to the United States. Remote follow-up consultations begin within two weeks via secure video call from the comfort of your home.

Frequently Asked Questions

Common Questions from American Patients

Why isn't this treatment available in the United States?
The FDA classifies UC-MSC therapy as an investigational drug for most conditions, meaning it cannot be commercially offered in the US outside of approved clinical trials. This is a regulatory classification, not a reflection of the therapy's safety profile. Boston Health Longevity operates under Thailand's regulatory framework, which supports the responsible clinical provision of these treatments.
Do I need a visa to visit Thailand from the US?
No. US passport holders can enter Thailand visa-free for up to 60 days. No visa application or embassy visit is required before travel. This is sufficient for treatment, recovery, and any additional time you wish to spend in Chiang Mai.
Will my US health insurance cover this treatment?
US health insurance typically does not cover overseas regenerative treatments, particularly those classified as investigational domestically. We provide detailed medical invoices and treatment documentation that you may be able to use for HSA or FSA reimbursement, or for out-of-pocket medical deductions. We recommend consulting your insurance provider and tax adviser for your specific situation.
How do I transport my medical records from the US?
Medical records are reviewed remotely before your trip. We accept scanned or digital copies of imaging (MRI, CT, X-ray), blood panels, specialist reports, and any relevant clinical history. Our patient coordination team guides you through the document preparation process.
Is it safe to fly long-haul after treatment?
Your clinical team will advise on the appropriate time to travel based on your specific treatment and condition. We recommend allowing at least one full recovery day in Chiang Mai before your return flight. For long-haul US flights, compression stockings and regular movement during the flight are strongly recommended.
How does Boston Health Longevity differ from other stem cell clinics marketed to Americans?
Boston Health Longevity uses only GMP-certified, umbilical cord-derived MSCs with full certificates of analysis and sterility testing. Every protocol is designed by a credentialled physician team led by Dr Michael Ackland, MBBS (Hons), FRACGP. We do not offer uncharacterised cell products, exaggerated outcome claims, or treatments without thorough patient assessment. Transparent informed consent and structured follow-up are integral to every programme.
What conditions do American patients most commonly seek treatment for?
The most common enquiries from US patients include osteoarthritis (knee, hip, shoulder), neurological conditions (MS, Parkinson's, neuropathy), autoimmune disorders (lupus, rheumatoid arthritis, Crohn's), and anti-ageing and longevity protocols. We assess each patient individually to determine suitability.
How do I get started?
Complete our online application form or contact us directly. A US-English-speaking coordinator will respond within 24 hours. The first step is a remote consultation where your medical history, imaging, and condition are reviewed by our clinical team to determine whether stem cell therapy may be appropriate for you.

Medically Reviewed

This page has been reviewed by Dr Michael Ackland, MBBS (Hons), FRACGP, Lead Medical Strategist at Boston Health Longevity, based at our Boston, USA clinic. Last reviewed: March 2025.

Medical Disclaimer

The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.

Begin Your Journey from New York

If you are a American patient interested in stem cell therapy, apply for a consultation. Our dedicated coordinator will guide you through every step.

52

Conditions Treated

11

Countries Served

GMP

Certified Supply

Apply for Consultation
Apply for Consultation